Home > Insider Trading > Filing (0001578563-20-000013)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1330436	Liquidia Technologies Inc	LQDA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033409	N Fredric Eshelman	C/O Eshelman Ventures, Llc 319 N. 3Rd Street, Suite 301 Wilmington NC 28401		No	No	Yes	No
1706673	Eshelman Ventures, Llc	319 N. 3Rd Street, Suite 301 Wilmington NC 28401		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-04-03	35,000	$4.85	131,323	No	4	P	Indirect	By Fred Eshelman, manager of Eshelman Ventures, LLC
Common Stock	Acquisiton	2020-04-06	44,250	$5.28	175,573	No	4	P	Indirect	By Fred Eshelman, manager of Eshelman Ventures, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Fred Eshelman, manager of Eshelman Ventures, LLC
No	4	P	Indirect	By Fred Eshelman, manager of Eshelman Ventures, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,159,744	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $4.45 to $5.20. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.
This transaction was executed in multiple trades at prices ranging from $5.12 to $5.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.
The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by the Dr. Eshelman, who is the manager of the Reporting Person.